loader image
January 2023 Banner
State Visit to Vietnam
MicrosoftTeams-image (5)
MicrosoftTeams-image (4)
COVID19 UPDATES
CC Slide banner
Slide
Slide
Slide 1
IEC
previous arrow
next arrow

Featured Activity

Featured Activity || DG Zacate Graced the 1st General Membership Meeting of PCPI

Director General Dr. Samuel A. Zacate of the Food and Drug Administration (FDA) graced the 1st General Membership Meeting (GMM)...
Read More
Featured Activity || DG Zacate Graced the 1st General Membership Meeting of PCPI

Featured Activity || Cascading of FDA-Related Laws, Rules, and Regulations

In a two-day Cascading of FDA-related laws, rules and regulations initiated by the Policy and Planning Service (PPS), respective lawyers...
Read More
Featured Activity || Cascading of FDA-Related Laws, Rules, and Regulations

Featured Activity || FDA Hosted the NALECC-SCOC 119th Regular Meeting

On March 20, 2024, the Food and Drug Administration Philippines hosted the 119th Regular Coordination Meeting of the National Law...
Read More
Featured Activity || FDA Hosted the NALECC-SCOC 119th Regular Meeting

Featured Activity || FDA DG Zacate Met with DA Secretary Laurel Jr.

Following President Ferdinand “Bongbong” R. Marcos Jr.'s directive during the Private Sector Advisory Council (PSAC) Health Sector Group Meeting ng...
Read More
Featured Activity || FDA DG Zacate Met with DA Secretary Laurel Jr.

Featured Activity || FDA and PEZA Introduces Pharmaceutical-Medical device (Pharma-Dev Zones) Ecozones to Accelerate Medical Manufacturing

Manila, Philippines - March 14, 2024 - The Philippine Economic Zone Authority (PEZA) is proud to unveil Pharmaceutical and Medical...
Read More
Featured Activity || FDA and PEZA Introduces Pharmaceutical-Medical device (Pharma-Dev Zones) Ecozones to Accelerate Medical Manufacturing

Featured Activity || FDA, PRC, and PRBOP Inked Memorandum of Agreement

The Ceremonial Signing of the Memorandum of Agreement (MOA) among the Food and Drug Administration (FDA), the Professional Regulation Commission...
Read More
Featured Activity || FDA, PRC, and PRBOP Inked Memorandum of Agreement

Featured Activity || DG Zacate Visits FDA RFO II in Tuguegarao City, Cagayan

Food and Drug Administration (FDA) Director General Dr. Samuel A. Zacate embarked on an ocular inspection at the FDA Regional...
Read More
Featured Activity || DG Zacate Visits FDA RFO II in Tuguegarao City, Cagayan

Featured Activity || FDA DG Zacate Pays a Courtesy Visit to the Tuguegarao City Mayor

Food and Drug Administration (FDA) Director General Dr. Samuel Zacate paid a courtesy visit to Mayor Maila Ting-Que of Tuguegarao...
Read More
Featured Activity || FDA DG Zacate Pays a Courtesy Visit to the Tuguegarao City Mayor

Featured Activity || LAB for ALL in Tuguegarao City, Cagayan

The Food and Drug Administration, under the leadership of Director General Dr. Samuel A. Zacate, continues to support the LAB...
Read More
Featured Activity || LAB for ALL in Tuguegarao City, Cagayan

Featured Activity || FDA Training for the Bureau of Customs

In a collaborative effort to ensure the smooth flow of health products across borders, the Food and Drug Administration (FDA)...
Read More
Featured Activity || FDA Training for the Bureau of Customs

Our Services

For Products and Establishments registration at FDA

Verification Portal

Check the List of Approved FDA
Authorizations

eServices Portal

New Online Application System for FDA Authorizations

ePortal System

Apply and Register for License to Operate, Certificate of Product Registration, and other FDA Authorizations

ePortal v.2 System

Authorizations for HUHS and Novel Tobacco Products

RRDportal

Applications for Licensing and Registration of Radiation Facilities and Other Related Authorizations

Verification Portal

Verification Portal

Check the List of Approved FDA
Authorizations

eServices

eServices Portal

New Online Application System for FDA Authorizations

ePortal

ePortal System

Apply and Register for License to Operate, Certificate of Product Registration, and other FDA Authorizations

v2 ePorta1

ePortal v.2 System

Authorizations for HUHS and Novel Tobacco Products

RRDportal_icon

RRDportal

Applications for Licensing and Registration of Radiation Facilities and Other Related Authorizations

COVID19-related Updates

(Click Logo below for Updates)

Latest Advisories

FDA Advisory No.2024-0543 || ON-BOARDING OF THE LICENSING PROCEDURES FOR HOUSEHOLD/URBAN HAZARDOUS SUBSTANCES (HUHS) ESTABLISHMENTS ON THE FOOD AND DRUG ADMINISTRATION (FDA) ESERVICES PORTAL SYSTEM

The Food and Drug Administration (FDA) continues its digital system enhancement through the development of online application platforms, particularly, the...
Read More

FDA Advisory No.2024-0542 || Resumption of the Conduct of Foreign GMP Inspection

Following the declaration of the World Health Organization (WHO), stating that COVID-19 no longer constitutes a public health emergency of...
Read More

FDA Advisory No.2024-0541 || Public Health Warning Against False Endorsement of FDA and Misleading Social Media Endorsements

The Food and Drug Administration (FDA) warns the public regarding false endorsements of health products through social media platforms. The...
Read More

FDA Advisory No.2024-0540 || Releasing of Food and Drug Administration Authorization at the Information and Communication Technology Management Division (ICTMD)-Records Section-Releasing Unit (RS-RU).

Releasing of Food and Drug Administration (FDA) approved authorizations and documents at the Records Section – Releasing Unit is essential...
Read More

FDA Advisory No.2024-0538 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products:

The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More

FDA Advisory No.2024-0539 || Full Implementation of FDA Circular No. 2021-021 Entitled “Guidelines on the Licensing of Retailers of Medical Devices in the Philippines”

On 7 October 2021, FDA Circular (FC) No. 2021-021 was issued to provide specific guidelines on the licensing of retailers...
Read More

FDA Advisory No.2024-0536-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:

Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na hindi rehistradong...
Read More

FDA Advisory No.2024-0536 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:

The Food and Drug Administration (FDA) advises the public against the purchase and use of the following unregistered drug products:...
Read More

FDA Advisory No.2024-0537 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement “NUTRA CHAMPS DREAMRITE Relaxing Herbal Sleep Aid Dietary Supplement”

The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More

Announcement

FDA SYSTEM MAINTENANCE ADVISORY
The Food and Drug Administration (FDA) – Policy and Planning Service- Information and Communication Technology Management Division (PPS-ICTMD) will conduct ...
Read More
FDA has released a total of 282 COVID – 19 Test Kits (99 – PCR based, 97 – Rapid Antibody, 59 – Immunoassay and 27 – Others)
As of 20 October 2020, FDA has released a total of 282 COVID – 19 Test Kits (99 – PCR ...
Read More

FDA on the News

FDA on the News || QC gov’t at FDA sanib pwersa para palakasin ang MSMEs

Nakipagsanib puwersa ang lokal na pamahalaan ng Quezon City sa Food and Drug Administration para palakasin pa ang Micro, Small,...
Read More

FDA on the News || LGU, FDA kapit-bisig sa pagpapalago sa MSMEs sa QC

MANILA, Philippines – NAIS palawakin pa ng Quezon City Local Governmemt ang suporta para sa mga Micro Small and Medium...
Read More

FDA on the News || QC, FDA ink assistance agreement for MSMEs

The Quezon City government and the Food and Drug Administration (FDA) signed on Friday, April 14, a memorandum of agreement...
Read More

FDA on the News || QC gov’t partners with FDA to aid MSMEs

MANILA, Philippines — The Quezon City government has joined forces with the Food and Drugs Administration (FDA) to support micro,...
Read More

FDA on the News || QC, FDA ink agreement to aid MSMEs

MANILA – The Quezon City local government and the Food and Drug Administration (FDA) have agreed to work together to help...
Read More

FDA on the News || QC, FDA partner on micro business development

In a bid to help micro, small and medium enterprises (MSMEs), the Quezon City government on Friday partnered with the...
Read More

FDA on the News || Quezon City LGU at FDA, kapit-bisig sa pagpapalago ng MSMEs

MANILA, Philippines — Palalawakin pa ng Quezon City Local Government ang suporta para sa mga Micro Small and Medium Enterprises...
Read More

FDA on the News || Quezon City, FDA to help MSMEs create more jobs (MANILA TIMES)

QUEZON City Mayor Maria Josefina "Joy" Belmonte on Friday announced that the local government has joined forces with the Food...
Read More

FDA on the News || The Quezon City government yesterday partnered with the Food and Drug Administration (FDA) to provide technical assistance and training for micro, small and medium enterprises (MSMEs) in the city.

The partnership is part of the city’s Bigyang-Halaga, Bangon MSMEs (BBMSME) program, which aims to streamline registration processes and make...
Read More

FDA on the News || SMNI News: Quezon City at FDA, lumagda ng kasunduan upang tulungan ang MSMEs

Mabibigyan ng pagkakataon ang mga Micro, Small, and Medium Enterprises ng Lungsod ng Quezon na mapadali at maintindihan ang pagkakaroon...
Read More

Press Statements

FDA Press Statement || Karapatan ng mga Senior Citizens sa 20% Discount, Binigyan-diin ng FDA

Bilang suporta sa direktiba ni Pangulong Ferdinand “Bongbong” R. Marcos Jr. na bigyang-diin ang pagsunod sa Republic Act 9994 o...
Read More

FDA Press Statement || Pag-apruba ng Generic Drug mas Pinaikli, Mula 120 Working Days, 45 Days na lang

Alinsunod sa direktiba ng Pangulong Ferdinand R. Marcos Jr. na magbigay tugon at gawing mabisa at mapabilis ang serbisyo ng...
Read More

Press Release || THE FOOD AND DRUG ADMINISTRATION (FDA) LAUNCHES TASKFORCE ALECTRYON TO FOCUS ON THE EVALUATION OF AVIAN FLU VACCINE

“THE FOOD AND DRUG ADMINISTRATION (FDA) LAUNCHES TASKFORCE ALECTRYON TO FOCUS ON THE EVALUATION OF AVIAN FLU VACCINE” In its...
Read More

FDA Press Statement || Food and Drug Administration’s (FDA) Commitment to Public Health Protection and Establishment of Technical Working Group (TWG) “Oplan Katharos”

The Food and Drug Administration (FDA) is unwavering in its dedication to safeguarding public health against the proliferation of counterfeit, adulterated,...
Read More

FDA Press Statement || Food and Drug Administration’s (FDA) Commitment to Public Health Protection and Establishment of Technical Working Group (TWG) “Oplan Katharos”

The Food and Drug Administration (FDA) is unwavering in its dedication to safeguarding public health against the proliferation of counterfeit,...
Read More

FDA Press Statement || FDA joins #MedSafetyWeek 2023

Play your part in medicines safety. Whether you’re a patient, doctor, nurse, or pharmacist, you can help make medicines safer...
Read More

FDA Press Statement || Press Release on the F-Pop Initiative

The Food and Drug Administration (FDA) is pleased to announce the launch of the Functional Pop Beauty “F-Pop” Initiative, a...
Read More

FDA Press Statement || FDA – DTI Price Monitoring at Inspection sa Divisoria 18 August 2023

Nakiisa ang Food and Drug Administration (FDA) sa isinagawang price monitoring and inspection ng Department of Trade and Industry (DTI)...
Read More

FDA Press Statement || Arrest of Chinese national for violation of RA 3720, RA 9711 and the Consumer Act of the Philippines

On June 26, 2023, the Food and Drug Administration North Luzon Regulatory Enforcement Unit (REU) together with the Criminal Investigation...
Read More
Transparency-Seal

FOI

ISO

Citizens-Charter

GAD

Verification-Logo

Pharmacovigilance

Pharmacovigilance

Draft for Comments

Draft for Comments || Prescribing the Guidelines on Good Manufacturing Practice (GMP) for Drug Manufacturers Repealing AO No. 2013-0022

The Food and Drug Administration through the Policy and Planning Service is hereby posting the attached proposed Administrative Order titled,...
Read More
Draft for Comments || Prescribing the Guidelines on Good Manufacturing Practice (GMP) for Drug Manufacturers Repealing AO No. 2013-0022

Draft for Comments || Prescribing the Rules and Regulations on the Registration of Pharmaceutical Products, including Drug Substances, Intended Solely for Export

All comments are requested to be submitted in MS Word Format via e-mail to [email protected]. The deadline for submission of...
Read More
Draft for Comments || Prescribing the Rules and Regulations on the Registration of Pharmaceutical Products, including Drug Substances, Intended Solely for Export

Draft for Comments || Supplemental Guidelines on the Management and Conduct of Product Recall for Prepackaged Processed Food Products

Kindly submit your comments in MSWord format on or before 15 March 2024 via email to [email protected] using the format attached.  ...
Read More
Draft for Comments || Supplemental Guidelines on the Management and Conduct of Product Recall for Prepackaged Processed Food Products

Draft for Comments || Prescribing the Rules, Requirements and Procedures in the Application for License to Operate of Covered Health Product Establishments with the Food and Drug Administration Repealing for the Purpose Administrative Order No. 2020-0017

The Food and Drug Administration through the Policy and Planning Service is hereby posting the attached proposed Administrative Order entitled,...
Read More
Draft for Comments || Prescribing the Rules, Requirements and Procedures in the Application for License to Operate of Covered Health Product Establishments with the Food and Drug Administration Repealing for the Purpose Administrative Order No. 2020-0017

Draft for Comments || Extension of the Regulatory Flexibility for Class B, C and D Medical Devices that are Not Included in the List of Registrable Medical Devices Based on FDA Circular No. 2020-001-A entitled “Amendment to Annex A of FDA Circular No. 2020-001 re: Initial Implementation of Administrative Order No. 2018-0002 “Guidelines Governing the Issuance of an Authorization for a Medical Device based on the ASEAN Harmonized Technical Requirements””

All comments may be sent to [email protected]. The deadline for submission of comments is on 22 February 2024. I. RATIONALE...
Read More
Draft for Comments || Extension of the Regulatory Flexibility for Class B, C and D Medical Devices that are Not Included in the List of Registrable Medical Devices Based on FDA Circular No.  2020-001-A entitled “Amendment to Annex A of FDA Circular No. 2020-001 re: Initial Implementation of Administrative Order No. 2018-0002 “Guidelines Governing the Issuance of an Authorization for a Medical Device based on the ASEAN Harmonized Technical Requirements””

Draft for Comments || Guidelines for the Classification of Vitamins and Minerals for Food/Dietary Supplements under Processed Food Product Repealing the Provisions for Food in the Office Order No. 22 s. 1991 entitled “Guidelines for the Classification of Vitamins and Minerals as Drug or as Food”

Please be informed that the CFRR has drafted the attached FDA Circular entitled “Guidelines for the Classification of Vitamins and...
Read More
Draft for Comments || Guidelines for the Classification of Vitamins and Minerals for Food/Dietary Supplements under Processed Food Product Repealing the Provisions for Food in the Office Order No. 22 s. 1991 entitled “Guidelines for the Classification of Vitamins and Minerals as Drug or as Food”

Draft for Comments || Guidelines on the Recall of Health Products Regulated by the Food and Drug Administration

All concerned stakeholders may submit comments in MS word format via email to [email protected]. The deadline for submission of comment...
Read More
Draft for Comments || Guidelines on the Recall of Health Products Regulated by the Food and Drug Administration

Draft for Comments || Amendment to FDA Circular No. 2022-004 entitled “Implementing Guidelines on the Abridged and Verification Review Pathways for New Drug Registration Applications in accordance with Administrative Order No. 2020-0045 Establishing Facilitated Registration Pathways for Drug Products including Vaccines and Biologicals” to include Generic Drug Registration Applications and update the list of Reference Drug Regulatory Agencies

All comments may be sent to [email protected]. The deadline for submission of comments is on 05 January 2024.   In...
Read More
Draft for Comments || Amendment to FDA Circular No. 2022-004 entitled “Implementing Guidelines on the Abridged and Verification Review Pathways for New Drug Registration Applications in accordance with Administrative Order No. 2020-0045 Establishing Facilitated Registration Pathways for Drug Products including Vaccines and Biologicals” to include Generic Drug Registration Applications and update the list of Reference Drug Regulatory Agencies

Draft for Comments || Rules and Regulations Governing the Issuance of Authorizations for Toys and Childcare Articles

The Center for Cosmetics and Household/Urban Hazardous Substances Regulation and Research (CCHUHSRR) is hereby circulating the draft of the attached...
Read More
Draft for Comments || Rules and Regulations Governing the Issuance of Authorizations for Toys and Childcare Articles

Draft for Comments || Submission of Position Paper/Comments on the Draft Administrative Order entitled “Implementing Guidelines on the Schedule of Fees and Charges of the Food and Drug Administration for Licensing, Registration and Other Authorizations and Regulatory Services Repealing Administrative Order No. 50s. 2001, “Revised 2001 Schedule of Fees and Charges for the Corresponding Services Rendered by the Bureau of Food and Drugs” and its Amendments

This refers to the public consultation on the FDA's new schedule of Fees and Charges conducted virtually on 27 October...
Read More
Draft for Comments || Submission of Position Paper/Comments on the Draft Administrative Order entitled “Implementing Guidelines on the Schedule of Fees and Charges of the Food and Drug Administration for Licensing, Registration and Other Authorizations and Regulatory Services Repealing Administrative Order No. 50s. 2001, “Revised 2001 Schedule of Fees and Charges for the Corresponding Services Rendered by the Bureau of Food and Drugs” and its Amendments

Bids and Awards

ITB No. 2024-0042-CSL || Supply, Delivery, Installation, Commissioning, And Testing of Brand-New Chromatographs complete with all necessary parts and accessories for Common Services Laboratory (CSL) – Cebu and Davao Testing and Quality Assurance Laboratories (CTQAL and DTQAL)

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Supply, Delivery, Installation, Commissioning, And Testing of Brand-New Chromatographs complete with all necessary parts...
Read More
ITB No. 2024-0042-CSL || Supply, Delivery, Installation, Commissioning, And Testing of Brand-New Chromatographs complete with all necessary parts and accessories for Common  Services Laboratory (CSL) – Cebu and Davao Testing and Quality Assurance Laboratories (CTQAL and DTQAL)

ITB No. 2024-0041-CSL || Supply, Delivery, Installation, Commissioning, And Testing of Brand-New Spectrophotometers complete with all necessary parts and accessories for Common Services Laboratory (CSL) – Alabang and Cebu Testing and Quality Assurance Laboratories (ATQAL and CTQAL)

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Supply, Delivery, Installation, Commissioning, And Testing of Brand-New Spectrophotometers complete with all necessary parts...
Read More

ITB No. 2024-0036-CSL || Procurement for the Calibration, Preventive Maintenance, and Recertification of Various Laboratory Equipment of CSL (ATQAL, CTQAL, DTQAL, and PLSD)

  Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Calibration, Preventive Maintenance, and Recertification of Various Laboratory Equipment of...
Read More
ITB No. 2024-0036-CSL || Procurement for the Calibration, Preventive Maintenance, and Recertification of Various Laboratory Equipment of CSL (ATQAL, CTQAL, DTQAL, and PLSD)

NP-SVP(A)-2024-0020-FDA-REPOST || Procurement of Three (3) Consecutive Periodic Maintenance Services of Service Vehicles of the Food and Drug Administration (Line Item)

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Three (3) Consecutive Periodic Maintenance Services of Service Vehicles of the Food...
Read More
NP-SVP(A)-2024-0020-FDA-REPOST || Procurement of Three (3) Consecutive Periodic Maintenance Services of Service Vehicles of the Food and Drug Administration (Line Item)

REI-2024-0009-FROO || Procurement of Consulting Services for the ISO/IEC 17020:2012 Pre-Accreditation of the Food and Drug Administration – Field Regulatory Operations Office (FDA-FROO)

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Consulting Services for the ISO/IEC 17020:2012 Pre-Accreditation of the Food and Drug...
Read More
REI-2024-0009-FROO || Procurement of Consulting Services for the ISO/IEC 17020:2012 Pre-Accreditation of the Food and Drug Administration – Field Regulatory Operations Office (FDA-FROO)

NP-SVP(A)-2024-0008-AFS || Procurement for the Supply, Delivery and Services of Four (4) Pieces of Tubeless Tires for the FDA Service Vehicle for Toyota Fortuner with Plate No. SAB-5286

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Supply, Delivery and Services of Four (4) Pieces of Tubeless Tires...
Read More
NP-SVP(A)-2024-0008-AFS || Procurement for the Supply, Delivery and Services of Four (4) Pieces of Tubeless Tires for the FDA Service Vehicle for Toyota Fortuner with Plate No. SAB-5286

NP-SVP(A)-2024-0020-FDA || Procurement of Three (3) Consecutive Periodic Maintenance Services of Service Vehicles of the Food and Drug Administration

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Three (3) Consecutive Periodic Maintenance Services of Service Vehicles of the Food...
Read More
NP-SVP(A)-2024-0020-FDA || Procurement of Three (3) Consecutive Periodic Maintenance Services of Service Vehicles of the Food and Drug Administration

NP-SVP(A)-2023-0321-SLC || Procurement of Five (5) 3-In-1 Multi-Purpose (Printer-Monochrome and Colored, Photocopier and Scanner)

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Five (5) 3-In-1 Multi-Purpose (Printer-Monochrome and Colored, Photocopier and Scanner)    
Read More
NP-SVP(A)-2023-0321-SLC || Procurement of Five (5) 3-In-1 Multi-Purpose (Printer-Monochrome and Colored, Photocopier and Scanner)

ITB No. 2023-0323-AFS-EPA || Procurement of Security Services for the food and Drug Administration (FDA) – Central Office, Alabang, Muntinlupa City (Including FDA Warehouse and CSL-SSDL at Fabella Hospital, DOH-Manila) for CY 2024

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Security Services for the food and Drug Administration (FDA) - Central Office,...
Read More
ITB No. 2023-0323-AFS-EPA || Procurement of Security Services for the food and Drug Administration (FDA) – Central Office, Alabang, Muntinlupa City (Including FDA Warehouse and CSL-SSDL at Fabella Hospital, DOH-Manila) for CY 2024

ITB No. 2023-0322-AFS-EPA || Procurement of Janitorial and Maintenance Services for the Food and Drug Administration (FDA) – Central Office, Alabang, Muntinlupa City for CY 2024

Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Janitorial and Maintenance Services for the Food and Drug Administration (FDA) –...
Read More
ITB No. 2023-0322-AFS-EPA || Procurement of Janitorial and Maintenance Services for the Food and Drug Administration (FDA) – Central Office, Alabang, Muntinlupa City for CY 2024

Latest Issuances

FDA Circular No.2024-001 || Recall and Withdrawal of the Classification and Registration of Domperidone as Over-the-Counter Drug

I. BACKGROUND It is the policy of the State to promote and protect the right to health of the people...
Read More

FDA Circular No.2023-012 || Recognition of Accredited Technical Service Providers for Radiation Dosimetry of Individual Monitoring Services

I. BACKGROUND The Food and Drug Administration, though the Center for Device Regulation, Radiation Health, and Research (FDA -CDRRHR) is...
Read More

FDA Circular No.2023-011 || Updates and Amendments to the ASEAN Cosmetic Directive (ACD) as Adopted During the 37th ASEAN Cosmetic Committee (ACC) Meeting and its Related Meetings

I. BACKGROUND In 2005, the Department of Health (DOH) – Food and Drug Administration (FDA), then Bureau of Food and...
Read More

FDA CIRCULAR No.2023-010 || Guidelines on the Conduct of the Food and Drug Administration Trainings and Seminars Offered by the FDA Academy to the External Stakeholders

I. RATIONALE The Food and Drug Administration (FDA) through the FDA Academy conducts training programs for its stakeholders on health...
Read More
Shares